期刊
EXPERT OPINION ON EMERGING DRUGS
卷 13, 期 2, 页码 383-392出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728214.13.2.383
关键词
antiobesity drugs; carbonic anhydrase; lipogenesis; topiramate; zonisamide
Background: Obesity is a widespread disease in both the developed and developing world. Few pharmacological approaches for its treatment exist at this time. Objective: This review summarises the currently approved obesity therapies and describes a possible new approach for the treatment and prophylaxis of this disease, based on the inhibition of carbonic anhydrases (CAs, EC 4.2.1.1), enzymes involved in several steps of de novo lipogenesis, both in the mitochondria and the cytosol of cells. Methods: Topiramate and zonisamide, two antiepileptic drugs showing strong CA inhibitory properties, have been reported as an example of this approach, as clinical data have shown that these compounds induce persistent weight loss in obese patients. Conclusions: The use of topiramate and zonisamide as lead molecules for the design of CA inhibitors targeting isozymes involved in lipogenesis could represent the beginning of a very promising new approach for the treatment of obesity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据